<DOC>
	<DOCNO>NCT00780429</DOCNO>
	<brief_summary>Study pharmacokinetic pharmacodynamic variability mycophenolate mofetil renal transplant patient already long-term MMF treatment ( least 6 month post-transplant ; least 3 month therapy ) . Study hypothesis : investigate whether long-term MMF therapy alters IMPDH biological activity correlation risk AR .</brief_summary>
	<brief_title>Pharmacokinetics Pharmacodynamics MPA Stable Renal Transplant Patients</brief_title>
	<detailed_description />
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<criteria>Renal transplant recipient Age range : 1870 Patients take MMF Able understand sign inform consent Active myelodepression Systemic infection may affect MMF absorption Pregnancy/breastfeeding ( History ) cancer Drug abuse , psychiatric condition Already enrol clinical trial participation end less one month earlier Known sensitivity polysorbate 80 MMF</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>kidney</keyword>
	<keyword>transplant</keyword>
	<keyword>Mycophenolic acid</keyword>
	<keyword>Inosine monophosphate dehydrogenase</keyword>
</DOC>